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ABSTRAK
Polimorfisme nitrat sintase endothelial (eNOS) rs1799983 telah dikenalpasti dapat 
meningkatkan risiko terhadap strok, tetapi tiada data yang dilaporkan dalam 
negara Malaysia. Oleh itu, kajian ini bertujuan untuk mengkaji perkaitan ini dalam 
populasi Malaysia dan dalam meta-analisis secara menyeluruh. Pengenotipan 
eNOS rs1799983 polimorfisme telah dilakukan bagi 241 rakyat Malaysia dengan 
menggunakan tanda hidrolisis. Nisbah ganjil dengan selang keyakinan 95% telah 
dikira. Meta-analisis dijalankan dengan perisian Comprehensive Meta-Analysis Ver. 
2.2.064. Nilai p kurang daripada 0.05 dianggap signifikan secara statistik. Secara 
keseluruhannya, kami menunjukkan bahawa alel eNOS rs1799983-T meningkatkan 
risiko terhadap strok terutamanya dalam kalangan lelaki, mereka yang kerap makan 
makanan segera dan bangsa Cina Malaysia. Meta-analisis menunjukkan bahawa 
polimorfisme rs1799983 dikaitkan dengan peningkatan risiko terhadap strok iskemia 
dalam model resesif dan alelik. Selepas stratifikasi mengikut populasi, perkaitan 
ini kekal signifikan dalam populasi Asia tetapi tidak signifikan dalam populasi 
Kaukasia. Kesimpulannya, kajian ini mendapati bahawa terdapat hubungan yang 
signifikan antara polimorfisme eNOS rs1799983 dengan perbezaan jantina, gaya 
hidup dan bangsa dalam mempengaruhi risiko terhadap strok di dalam populasi 
Malaysia. Di samping itu, meta-analisis kami mencadangkan bahawa polimorfisme 
eNOS rs1799983 dikaitkan dengan peningkatan risiko terhadap strok iskemia.
Kata kunci: eNOS, meta-analisis, polimorfisme nukleotida tunggal, rs1799983, strok 
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ABSTRACT
The endothelial nitric oxide synthase (eNOS) rs1799983 polymorphism is known to 
increase the risk towards stroke, but data is under-reported in Malaysian population. 
Therefore, this study sought to investigate this association in a Malaysian population 
and in a comprehensive meta-analysis. Genotyping of the eNOS rs1799983 
polymorphism was performed for 241 Malaysians using a hydrolysis probe. Odd 
ratio with 95% confidence interval was calculated. Meta-analysis was conducted 
using the Comprehensive Meta-Analysis software ver. 2.2.064. A p-value less than 
0.05 was considered statistically significant. Overall, our results showed that the 
presence of eNOS rs1799983-T allele increases the risk towards stroke, particularly 
in males, fast-food goers and Malaysian Chinese. The meta-analysis showed that 
the rs1799983 polymorphism is significantly associated with an increase ischemic 
stroke risk in the recessive and allelic models. After stratified with population, these 
associations remain significant in the Asian population but not in the Caucasian 
population. In summary, this study establishes a significant relationship between 
the eNOS rs1799983 polymorphism with gender, lifestyle and ethnicity differences 
towards stroke risk in the Malaysian population. In addition, our meta-analysis 
suggests that the eNOS rs1799983 polymorphism is associated with an increase 
risk of ischemic stroke. 
Keywords: eNOS, meta-analysis, rs1799983, single nucleotide polymorphism, stroke
Malaysia 2016). Stroke incidence 
in Malaysia is estimated to increase 
annually by 29.5% for ischemic stroke 
and 18.7% for haemorrhagic stroke 
(Aziz et al. 2015). 
 Stroke is a multifactorial disorder. 
Common health and habitual risks 
of stroke such as dyslipidemia, 
hypertension, atrial fibrillation, 
smoking, and diabetes mellitus have 
been long proposed but only explain 
a small proportion of the observed 
clinical events (Sacco et al. 1989). Twin 
and familial aggregation studies suggest 
that the risk of stroke is substantially 
influenced by the genetic component 
(Dichgans 2007). A recent study had 
suggested that genetic factors are highly 
INTRODUCTION
Stroke is the second leading cause of 
death and the third leading cause of 
disability worldwide (World Health 
Organization 2012), and it is also 
the leading cause of dementia and 
depression (Owolabi et al. 2015). It has 
been proposed that stroke accounts for 
nearly 5.7 million of deaths globally 
each year and 87% of these deaths 
occurred in the low and middle 
income nations (Strong et al. 2007). In 
Malaysia, stroke accounts for 7.1% of 
total death in year 2014, ranking stroke 
the third cause of deaths in the country 
after ischemic heart diseases and 
pneumonia (Department of Statistics 
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involved in ischemic stroke incidences 
through endothelial dysfunction 
(Meschia et al. 2011). Abnormalities in 
the endothelial nitric oxide synthase 
(eNOS) activity have been proposed 
to be one of the factors that contribute 
to endothelial dysfunction and lead to 
stroke incidences (Huang 2003).
 The eNOS gene is located at 
chromosome 7q36.1 with 26 exons 
(Marsden et al. 1993). This gene encodes 
the eNOS protein that produces nitric 
oxides (NO) that dilates all types of 
blood vessels by stimulating soluble 
guanylyl cyclase and increasing cyclic 
guanosine monophosphate in the 
smooth muscle cells (Forstermann et 
al. 1994), which helps in maintaining 
the resting cerebral blood flow and 
regulates neuronal activity (Faraci & 
Brian 1994). The NO released also 
act as a potent inhibitor of platelet 
aggregation and adhesion, implying 
that NO provides protection against 
the onset of atherogenesis and fibrous 
plaque formation (Fostermann & 
Munzel 2006) that will eventually lead 
to stroke incidences.
 The eNOS rs1799983 single 
nucleotide polymorphism (SNP) is 
located in the exon 7 that leads to 
the substitution of G to T at coding 
nucleotide position 894, resulting in 
the conversion of glutamate (Glu) to 
aspartic (Asp) at codon 298 (Hingorani 
et al. 1999; Ellul et al. 2011). This SNP 
was found to be associated with a 
reduction in the eNOS activity and 
led to the reduction of basal NO 
production (Tesauro et al. 2000; 
Veldman et al. 2002), impairing 
vasodilation in the endothelium and 
causing atherosclerosis and stroke 
incidences. 
 A large number of studies have 
been conducted to investigate the 
association of the eNOS rs1799983 
SNP with the risk of stroke, however, 
these studies have yielded inconsistent 
and conflicting results. Therefore, we 
conducted a case-control study to 
investigate this association in Malaysian 
population and subsequently pooled 
our results with other similar studies 
for a meta-analysis that would 
establish a comprehensive picture of 
the relationship between the eNOS 
rs1799983 SNP and stroke risk.  
MATERIALS AND METHODS
STUDY SUBJECTS AND ETHICS
A total of 103 blood samples were 
collected from confirmed stroke 
survivors at Hospital Queen Elizabeth, 
Sabah, Malaysia with informed 
consent. The stroke patients are 
randomly selected and retrospectively 
collected after being diagnosed with 
stroke by certified neurologists. In 
addition, blood samples from 138 
healthy individuals who did not 
have a stroke history, were collected. 
Information about age, gender, 
lifestyle (i.e. smoking status, alcohol 
consumption and fast-food intake) and 
ethnicity of both stroke patients and 
healthy controls were recorded. This 
study was approved by the Medical 
Research and Ethics Committee of 
the Ministry of Health, Malaysia with 
reference no. NMRR-16-38-28777 (IIR). 
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DNA EXTRACTION AND 
GENOTYPING
DNA was extracted from the peripheral 
blood samples using a salting out 
method with modifications from 
Sambrook & Russell (2002). Genotyping 
of the eNOS rs1799983 SNP was 
carried out using 0.5 μL of TaqMan® 
assay (assay ID: C___3219460_20) 
(ABI, Foster City, CA), 2 μL of 5 X HOT 
FIREPol® Probe Universal qPCR Mix 
(Solis BioDyne, Tartu, Estonia), 1 μL 
of genomic DNA (10-20 ng/μL) and 
6.5 μL of sterile distilled water with 
the following amplification protocol: 
preheated at 60oC for 30 seconds, 
denaturation at 95oC for 10 minutes, 
followed by 40 cycles of denaturation 
at 95oC for 18 seconds, and annealing/
extension at 60oC for 1 minutes. The 
genotyping was carried out using the 
StepOnePlusTM Real-time PCR System 
(ABI, USA) and the genotyping results 
were analyzed using the TaqMan® 
Genotyper Software Ver. 1.3 (ABI, 
USA).
META-ANALYSIS
Studies reported on the association 
between the eNOS rs1799983 SNP and 
stroke risk were retrieved by performing 
an extensive search in the PubMed 
database for English or Chinese 
literatures published before 31 January 
2018. Search term combinations 
are relating to rs1799983 and stroke 
such as “rs1799983”, “G894T” and 
“Glu298Asp” in combination with 
“stroke”, “cerebrovascular accident” 
and “cva”. We sought eligible studies 
which met the following criteria: i) 
original paper published based on 
case-control design assessing the 
association between eNOS rs1799983 
SNP (G894T/Glu298Asp) and stroke 
risk; ii) providing sufficient data for the 
calculation of genotypic odd ratio (OR) 
with 95% confidence interval (95% CI); 
iii) only ischemic stroke (IS) cases and 
its subtypes are being considered. The 
major reasons for exclusion of studies 
were: i) not case-control study (i.e. 
review articles, meta-analysis, clinical/
case-only studies, etc.); ii) those not 
reporting the eNOS rs1799983 SNP 
and stroke risk. The most recent and 
complete studies were chosen for 
overlapping data. 
 Titles, abstracts, and full texts of all 
the retrieved articles were screened 
carefully by following the inclusion 
and exclusion criteria stated above. 
Data such as first author’s name, year 
of publication, country, number of 
cases and controls, population group, 
genotyping method and genotype 
frequency were extracted. 
STATISTICAL ANALYSIS
In case-control study, the Hardy-
Weinberg equilibrium (HWE) in both 
cases and controls were assessed 
using the Chi-square test. OR with 
95% CI was calculated using the SPSS 
V.17.0 (IBM, USA). Association was 
considered statistical significant when 
the p-value was less than 0.05.
 In meta-analysis, OR with 95% 
CI was used to assess the strength of 
the association between the eNOS 
rs1799983 SNP with the risk of IS. 
The Pearson’s Chi-square test was 
used to test the deviation of the eNOS 
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rs1799983 SNP genotype distribution 
in control groups from the HWE. 
Association analysis was performed 
for dominant (GG versus GT+TT), 
recessive (TT versus GG+GT), allelic 
(G versus T), heterozygous (GG versus 
GT) and homozygous (GG versus TT) 
models. The I2 method (Higgins & 
Thompson 2002) was used to assess the 
heterogeneity among studies. Random 
effect model (REM) (DerSimonian & 
Laird 1986) was adopted as the pooling 
method if substantial heterogeneity 
was present (I2>50%) (Higgins et al. 
2003), otherwise, the fixed effect 
model (FEM) (Mantel & Haenszel 1959) 
was selected as the pooling method. 
In addition, sources of heterogeneity 
were investigated by stratifying the 
meta-analysis based on population 
subgroup.
 A funnel plot and the Egger’s linear 
regression test were used to assess 
evidence for potential publication bias 
(Egger et al. 1997). Begg’s test was used 
as an additional measure to detect 
publication bias (Begg & Majumdar 
1994). The Comprehensive Meta-
Analysis ver. 2.2.064 (Biostat, Inc., 
USA) was used to perform the meta-
analysis. 
Figure 1: Literature selection process for meta-analysis.
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Reference
Controls Cases
OR (95% CI) p
N N
Overall
  GG 108 71 1.00 (Reference) -
  GT 26 31 1.81 (0.99-3.31) 0.052
  TT 4 1 0.38 (0.04-3.47) 0.392
  GT + TT 30 32 1.62 (0.91-2.90 0.103
Gender
  Male 90 66
    GG 71 43 1.00 (Reference) -
    GT 17 22 2.14 (1.02-4.47) 0.044*
    TT 2 1 0.83 (0.07-9.38) 0.877
    GT + TT 19 23 2.00 (0.98-4.09) 0.058
 Female 48 37
    GG 37 28 1.00 (Reference) -
    GT 9 9 1.32 (0.46-3.76) 0.602
    TT 2 0 - -
    GT + TT 11 9 1.08 (0.39-2.96) 0.879
Smoking status
 Yes (≥ 2/day) 41 15
    GG 30 10 1.00 (Reference) -
    GT 11 5 1.36 (0.38-4.89) 0.634
    TT 0 0 - -
    GT + TT 11 5 1.36 (0.38-4.89) 0.634
 No 97 88
    GG 78 61 1.00 (Reference) -
    GT 15 26 2.22 (1.08-4.55) 0.030
    TT 4 1 0.32 (0.03-2.93) 0.313
    GT + TT 19 27 1.82 (0.92-3.57) 0.083
Alcohol consumption
 Yes (≥ 2/week) 30 12
    GG 24 7 1.00 (Reference) -
    GT 6 5 2.86 (0.67-12.24) 0.157
    TT 0 0 - -
    GT + TT 6 5 2.86 (0.67-12.24) 0.157
 No 108 91
    GG 84 64 1.00 (Reference) -
    GT 20 26 1.71 (0.88-3.33) 0.117
    TT 4 1 0.33 (0.04-3.01) 0.324
    GT + TT 24 27 1.48 (0.78-2.80) 0.232
Table 1: Stroke risk association of eNOS rs1799983 SNP in the Malaysian population
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Reference
Controls Cases
OR (95% CI) p
N N
Fast-food intake
 Yes (≥ 2/week) 100 83
    GG 84 58 1.00 (Reference) -
    GT 14 25  2.59 (1.24-5.39) 0.011*
    TT 2 0 - -
    GT + TT 16 25 2.26 (1.11-4.61) 0.024*
 No 38 20
    GG 24 13 1.00 (Reference) -
    GT 12 6 0.92 (0.28-3.03) 0.895
    TT 2 1 0.92 (0.08-11.17) 0.950
    GT + TT 14 7 0.92 (0.30-2.86) 0.890
Ethnicity
 Malay 14 9
    GG 10 8 1.00 (Reference) -
    GT 2 1 0.63 (0.05-8.20) 0.721
    TT 2 0 - -
    GT + TT 4 1 0.31 (0.03-3.38) 0.338
 Malaysian Chinese 68 20
    GG 59 13 1.00 (Reference) -
    GT 8 7 3.97 (1.22-12.91) 0.022*
    TT 1 0 - -
    GT + TT 9 7 3.53 (1.11-11.21) 0.033*
 Kadazan/Dusun 7 36
    GG 3 24 1.00 (Reference) -
    GT 4 12 0.38 (0.07-1.95) 0.244
    TT 0 0 - -
    GT + TT 4 12 0.38 (0.07-1.95) 0.244
 Others 49 38
    GG 36 26 1.00 (Reference) -
    GT 12 11 1.27 (0.49-3.32) 0.627
    TT 1 1 1.38 (0.08-23.17) 0.821
    GT + TT 13 12 1.28 (0.50-3.25) 0.606
* Statistically significant (p < 0.05).
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RESULTS
CHARACTERISTIC OF SUBJECTS
The case-control study consisted of 
103 stroke patients with 58 IS cases 
and 45 haemorrhagic (HS) cases. The 
mean age for stroke patients was 53.53 
+ 12.72 years while for the controls 
is 55.51 + 14.62 years. Both stroke 
patients and controls are age-matched 
as no significant mean difference 
was observed between their ages 
(p=0.275). 
RISK ASSOCIATION IN CASE-
CONTROL STUDY
Genotypic distribution for both 
cases and controls was found to 
be in HWE (p=0.229 for cases and 
p=0.133 for controls). No significant 
difference was found with respect 
to genotypic (p=0.086) and allelic 
(p=0.245) frequencies between the 
cases and controls. Overall, there 
was no significant association of the 
eNOS rs1799983 SNP with stroke risk 
in the Malaysian population (Table 1). 
However, we found that Malaysian 
males who were inherited the eNOS 
rs1799983-GT genotype had a 2-fold 
increased risk towards stroke. After 
stratified to lifestyles, our study revealed 
that subjects who consumed fast-
food regularly and inherited with the 
T allele of this SNP were significantly 
associated with more than a 2-fold 
higher risk of stroke. Besides that, we 
found that the Malaysian Chinese with 
the T-allele of the eNOS rs1799983 
SNP had a nearly 4-fold increased risk 
of stroke after the stratification based 
on ethnicity. 
RISK ASSOCIATION IN META-
ANALYSIS
A total of 19 studies with 4038 IS cases 
and 4604 controls were included 
in the meta-analysis (Figure 1). The 
distribution of genotypes in the control 
groups were in HWE, with exception 
of three included studies (Table 2).
 In overall, the eNOS rs1799983 SNP 
was significantly associated with an 
increased risk of IS in the recessive and 
allelic models. After the exclusion of 
studies with controls that deviated from 
the HWE, the association remained 
significant in these two models. When 
stratified to different populations, the 
genotype of the eNOS rs1799983 SNP 
in the control groups were found to be 
in HWE of all the studies in the Asian 
subgroup while 3 out of 5 studies in the 
Caucasian subgroup were found to be 
deviated from the HWE. Interestingly, 
an increase risk of IS associated with 
the eNOS rs1799983 SNP was strongly 
significant in the Asian population in 
the dominant, allelic and heterozygous 
models but no significant association 
was found in the Caucasian population 
in all the comparison models (Figure 2 
and Table 3).  
PUBLICATION BIAS ASSESSMENTS 
IN META-ANALYSIS
Funnel plots revealed no significant 
publication bias present in all the 
comparison models (Figure 3), which 
is further supported by the Egger’s and 
Begg’s tests where the p-values were 
less than 0.05 in all the comparison 
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Reference Country Population 
group
Genotyping 
method
No. of 
cases/
controls
Genotype (Cases/
Controls)
HWE in 
controls 
(p)
GG GT TT
Kumar et 
al., 2016
India Asian PCR-RFLP 250/250 164/186 74/59 12/5 0.02 
(0.8875)
Yan et al., 
2011
China Asian Taqman 545/557 417/446 123/102 5/9 1.25 
(0.2636)
Shyu et al., 
2017
Taiwan Asian Taqman 229/243 151/185 62/51 16/7 2.16 
(0.1416)
Esparza-
Garcia et 
al., 2015
Mexico Mexican PCR-RFLP 204/204 107/146 86/52 11/6 0.27 
(0.6033)
Xiong et 
al., 2012
China Asian SNP 
microarray
89/102 59/72 19/27 11/3 0.06 
(0.8065)
Saidi et al., 
2010
Tunisia African PCR-RFLP 329/444 98/229 170/174 61/41 0.9 
(0.3428)
Guldiken 
et al., 
2009
Turkey Asian PCR-RFLP 146/133 82/66 59/61 5/6 3.06 
(0.0802)
Szolnoki et 
al., 2005
Hungary Caucasian PCR-RFLP 407/295 205/144 179/137 23/14 6.87 
(0.0088*)
Elbaz et 
al., 2000
French Caucasian PCR-RFLP 460/460 212/163 187/232 61/65 1.48 
(0.2238)
Diakite et 
al., 2014
Morocco African PCR-RFLP 165/182 83/117 66/58 16/7 0 
(1.0000)
Kaur et al., 
2015
India Asian PCR-RFLP 120/101 84/83 30/17 6/1 0.02 
(0.8875)
Türkanoğlu 
Ozcelik et 
al., 2014
Turkey Caucasian PCR-RFLP 245/145 82/55 156/80 7/10 7.09 
(0.0078*)
Majumdar 
et al., 2010
India Asian PCR-RFLP 172/214 124/159 43/50 5/5 0.2 
(0.6547)
Djordjevic 
et al.,2009
Serbia Caucasian PCR-RFLP 26/50 13/18 7/25 6/7 0.13 
(0.7184)
Yemisci et 
al., 2009
Turkey Asian PCR-RFLP 67/81 23/22 36/47 8/12 2.58 
(0.1082)
Moe et al., 
2008
Singapore Asian PCR-RFLP 120/207 89/160 26/42 3/5 1.2 
(0.2733)
Howard et 
al., 2005#
USA Caucasian 
and 
America 
African
SNP 
microarray
109/198 69/109 33/75 7/14 0.05 
(0.8231)
Hassan et 
al., 2004
UK Caucasian PCR-RFLP 297/598 117/242 138/294 42/62 3.95 
(0.0469*)
Current 
Study
Malaysia Asian Taqman 58/138 40/108 17/26 1/4 2.26 
(0.1328)
*Control genotypes not in Hardy-Weinberg Equilibrium, p-value<0.05.   
#Excluded from ethnicity subgroup analysis because consists of multiple population group.
Table 2: Characteristics of the studies included in the meta-analysis
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Figure 2: Forest plots for association of eNOS rs1799983 SNP with ischemic stroke risk. (a) Dominant 
model; (b) Recessive model; (c) Allelic model; (d) Heterozygous model; (e) Homozygous model
models. 
DISCUSSION
The prevalence of eNOS 
polymorphisms has been established 
for Caucasian, African-American 
and Asian populations. However, 
limited information is available in the 
Malaysian population. In the present 
case-control study, no significant 
association was found between the 
eNOS rs1799983 SNP with stroke 
risk in the Malaysian population. A 
previous study based on a Singapore 
population that share a high similarity 
with the Malaysian population (in terms 
of multiple ethnicities) also reported 
similar findings (Moe et al. 2008). 
Interestingly, this SNP was found to be 
associated with a higher risk towards 
stroke in other Asian populations such 
as in Indian population (Kumar et 
al. 2016) and Taiwanese population 
(Shyu et al. 2017), indicating that the 
association of this SNP with stroke risk 
is ethnic-dependent as the populations 
in Malaysia and Singapore consist of 
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Sub-
group 
analysis
No. 
of 
study
No. of 
case/
control
Comparison 
model
Fixed effect model 
(FEM) 
Random effect model 
(REM) 
I2 (%)
OR (95% 
CI)
p-value OR (95% 
CI)
p-value
Overall 19 4038/ 
4602
Dominant 1.198 (1.093-
1.314)
0.000 1.210 (0.987-
1.483)S
0.067 77.591
Recessive 0.738 (0.619-
0.880)S
0.001 0.737 (0.562-
0.965)
0.027 44.055
Allelic 1.189 (1.106-
1.278)
0.000 1.215 (1.037-
1.423)S
0.016 76.366
Heterozygous 1.154 (1.048-
1.270)
0.004 1.157 (0.947-
1.412)S
0.153 74.304
Homozygous 1.389 (1.154-
1.672)
0.001 1.395 (0.983-
1.980)S
0.062 64.298
Excluded 
for 
DHWE#
16 3089/
3564
Dominant 1.258 (1.132-
1.398)
0.000 1.243 (0.968-
1.596)S
0.089 80.291
Recessive 0.700 (0.570-
0.861)S
0.001 0.677 (0.494-
0.927)
0.015 41.937
Allelic 1.248 (1.146-
1.359)
0.000 1.261 (1.036-
1.534)S
0.021 78.847
Heterozygous 1.206 (1.079-
1.347)
0.001 1.178 (0.922-
1.505)S
0.190 77.211
Homozygous 1.482 (1.193-
1.843)
0.000 1.524 (0.991-
2.343)S
0.055 67.029
Caucasian 5 1435/ 
1548
Dominant 0.873 (0.751-
1.015)
0.076 0.887 (0.685-
1.149)S
0.365 60.204
Recessive 0.922 (0.721-
1.178)S
0.514 0.938 (0.649-
1.355)
0.733 43.352
Allelic 0.953 (0.853-
1.064)S
0.388 0.957 (0.835-
1.098)
0.531 28.232
Heterozygous 0.850 (0.726-
0.994)
0.042 0.858 (0.641-
1.150)S
0.306 65.730
Homozygous 0.957 (0.737-
1.242)S
0.740 0.953 (0.650-
1.397)
0.805 41.779
Asian 10 1796/ 
2026
Dominant 1.255 (1.085-
1.452)S
0.002 1.249 (1.046-
1.491)
0.014 26.772
Recessive 0.713 (0.486-
1.046)S
0.083 0.712 (0.441-
1.151)
0.166 32.406
Allelic 1.238 (1.092-
1.403)S
0.001 1.244 (1.042-
1.486)
0.016 45.873
Heterozygous 1.215 (1.044-
1.413)S
0.012 1.208 (1.024-
1.425)
0.025 11.612
Homozygous 1.441 (0.975-
2.131)S
0.067 1.432 (0.854-
2.399)
0.173 38.954
 S Selected effect model based on I2 value (FEM if I2<50% and REM if I2>50%).
#Analysis excluded studies with control genotype deviating from Hardy-Weinberg equilibrium (DHWE)
Table 3: Meta-analysis of eNOS rs1799983 SNP with ischemic stroke risk
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multiple ethnic groups.
 After stratification according to 
gender, we found that Malaysian 
males with the eNOS rs1799983-GT 
genotype had a significant increase 
risk towards stroke. However, studies 
based on other populations such as 
the Morocco population (Diakite et 
al. 2014), Tunisian population (Saidi 
et al. 2010) and German population 
(Berger et al. 2007) had found that the 
association of this polymorphism with 
stroke was independent according 
to gender. The function of eNOS 
rs1799983 SNP has been well-studied 
but there are no studies reporting this 
SNP plays a different role in males and 
females. It is worth mentioning that the 
hormone oestrogen that is present in 
females may increases the production 
of NO, a potential vasodilator in the 
body (Kharitonov et al. 1994; Forte 
et al. 1998) that may aid in reducing 
stroke risk. Besides that, the study also 
showed that males have a higher risk 
of developing vascular diseases such 
Figure 3: Funnel plots for assessment of publication bias. (a) Dominant model (Egger: p=0.877, Begg: 
p=0.726). (b) Recessive model (Egger: p=0.936, Begg: p=1.000). (c) Allelic model (Egger: p=0.616, 
Begg: p=0.780). (d) Heterozygous model (Egger: p=0.960, Begg: p=0.484). (e) Homozygous model 
(Egger: p=0.937, Begg: p=1.000).
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as stroke than females (Whelton 1994). 
However, the NO level of the subjects 
were not measured in this study.
 When stratified to lifestyle, we 
found that subjects who inherited 
the T allele and consume fast-food 
regularly had a 2.5-fold increased 
risk towards stroke. This finding 
suggests that the risk towards stroke 
is influenced by the lifestyle factors 
such as diet. Fast-food are energy-
dense meals due to high content of 
fat, refined starch, and sugar, and 
correspondingly, lower water content 
(Benajiba 2016). Furthermore, fast-
food is highly processed and prepared 
using standardised ingredients and 
production procedures, usually rich 
in salts as food additives. A habit 
of consuming fast-food regularly 
increases the amount of salts intake 
on a daily basis as fast-food generally 
contains a relatively higher amount of 
salts when compared to homemade 
food. High salt intake from the fast-
food and processed food has been 
associated with a significantly greater 
risk of both strokes and cardiovascular 
diseases (Strazzullo et al. 2009). 
 In addition, it has been proposed 
that fast-food was associated with a 
low intake of vegetables, fruits and 
milk in both adults and children 
(Paeratakul et al. 2003). Indeed, green 
leafy vegetables were associated with 
a reduced likelihood of coronary heart 
disease and stroke (Joshipura et al. 
2001). This may due to the fact that 
85% of dietary nitrate (the inorganic 
nitrate anion, NO3
-) is derived from 
vegetables (Gangolli et al. 1994), 
and these nitrates are important 
in promoting vasodilatation and 
preventing vascular dysfunction that 
will lead to stroke. Studies have shown 
that nitrate dietary intakes from beetroot 
juice, beet-enriched bread, and 
inorganic nitrate supplements have a 
protective effect against cardiovascular 
diseases by reducing blood pressure, 
platelet aggregation inhibition, and 
prevention of endothelial dysfunction 
(Kapil et al. 2010; Hobbs et al. 2012). 
Besides, various natural products 
present in vegetables and fruits such 
as genistein improve endothelial nitric 
oxidase synthase, increase nitric oxide 
formation, reduce serum cholesterol 
levels, reduce inflammatory response, 
and hence, reduce the occurence of 
atherosclerosis and stroke (Lina et al. 
2018). 
 The T allele of the eNOS rs1799983 
SNP was associated with a reduced 
eNOS activity and a lower nitrate 
concentration in blood (Mahmoodi et 
al. 2016). Hence, the genetic factors 
(rs1799983-T allele reduces blood 
nitrate concentration) together with 
the dietary habits (high salt intake 
from fast-food and reduced nitrate 
intake from vegetables) may be the 
possible explanation for the significant 
association between subjects with 
rs1799983-GT genotype that consume 
fast-food regularly and a higher risk 
towards stroke.  
 In the present case-control study, 
we also found that Malaysian Chinese 
carrying the eNOS rs1799983-T allele 
had a nearly 4-fold increased risk of 
stroke. Our results are in aggreement 
with previous studies where the 
T-allele of the eNOS rs1799983 SNP 
was found to be associated with an 
increased stroke risk in Hans Chinese 
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(Xiong et al. 2012) and Taiwanese 
(Shyu et al. 2017). Hence, the eNOS 
rs1799983-T allele might be a potential 
biomarker for early stroke detection in 
Chinese ethnicity.
 We also performed a meta-analysis 
for this SNP by pooling our IS cases 
(n=58) with other similar studies. 
Only IS cases were included in the 
meta-analysis as it accounted for 85% 
of stroke incidences globally and to 
reduce between study heterogeneity 
due to different stroke subtypes since 
other studies included in the meta-
analysis only involving IS. A meta-
analysis based on the African and 
Mexican population subgroups was 
not performed owing to insufficient 
studies available (number of study: 
African=2; Mexican=1). 
 In meta-analysis, we demonstrated 
that there was a significant association 
of the eNOS rs1799983 SNP and IS 
risk in the recessive and allelic models. 
In the population subgroup analysis, 
the eNOS rs1799983 SNP revealed 
a significant increase risk with IS in 
the Asian population but not in the 
Caucasian population. Similar results 
were reported in the previous meta-
analyses (Kumar et al. 2017; Guo 
2014; Niu et al. 2013; Yao et al. 2013). 
Moreover, the TT genotype of the 
eNOS rs1799983 SNP is a higher risk 
factor for IS in the Asian population 
but it is protective against IS in the 
Caucasian population (Niu et al. 2013). 
These findings indicate that the eNOS 
rs1799983 SNP towards IS susceptibility 
is population-specific. Further research 
is warranted to clarify the relevance of 
this SNP to IS in Caucasian and Asian 
populations. 
 Present case-control study and meta-
analysis must be carefully interpreted 
because of certain limitations. First, we 
do not measure the blood NO level 
of both stroke patients and controls. 
Second, this meta-analysis solely 
focuses the genetic perspective but 
environmental factors and lifestyles 
that have been commonly associated 
with stroke were not included. Third, 
although we set a precise search 
strategy for retrieval of eligible studies, 
we cannot eliminate the possibilities 
that some studies that published in 
other databases were not included. 
CONCLUSION
In summary, our case-control study 
suggests that the T allele of the eNOS 
rs1799983 SNP increases the risk of 
stroke in the Malaysian population, 
particularly in Malaysian males, that 
consume fast-food regularly and 
Chinese ethnicity. In meta-analysis, 
the eNOS rs1799983 SNP is associated 
with a higher risk of IS in the Asian 
population but not in the Caucasian 
population. 
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